Sg Americas Securities, LLC Ardelyx, Inc. Transaction History

Sg Americas Securities, LLC

$29.7 Billion
Q3 2025

A detailed history of Sg Americas Securities, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 131,925 shares of ARDX stock, worth $774,399. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,925

Previous 21,466 514.58%

Holding current value

$774,399

Previous $84,000 765.48%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$3.92 - $6.64 $432,999 - $733,447	110,459 Added 514.58%	131,925 $727,000
Q2 2025 Aug 08, 2025	SELL	$3.28 - $5.51 $475,196 - $798,272	-144,877 Reduced 87.1%	21,466 $84,000
Q1 2025 Apr 15, 2025	BUY	$4.91 - $6.36 $547,253 - $708,866	111,457 Added 203.07%	166,343 $817,000
Q4 2024 Jan 17, 2025	BUY	$4.49 - $6.85 $72,657 - $110,846	16,182 Added 41.81%	54,886 $278,000
Q3 2024 Oct 03, 2024	SELL	$5.28 - $7.57 $279,671 - $400,967	-52,968 Reduced 57.78%	38,704 $267,000

Q2 2024 Jul 12, 2024	BUY	$5.89 - $9.31 $399,047 - $630,752	67,750 Added 283.21%	91,672 $679,000
Q1 2024 May 06, 2024	SELL	$6.05 - $9.74 $485,778 - $782,063	-80,294 Reduced 77.05%	23,922 $175,000
Q4 2023 Jan 12, 2024	SELL	$3.29 - $6.64 $341,291 - $688,807	-103,736 Reduced 49.88%	104,216 $646,000
Q3 2023 Oct 13, 2023	BUY	$3.3 - $4.83 $686,241 - $1 Million	207,952 New	207,952 $848,000
Q1 2022 Apr 29, 2022	SELL	$0.65 - $1.18 $14,384 - $26,113	-22,130 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$0.86 - $1.7 $22,708 - $44,888	-26,405 Reduced 54.4%	22,130 $24,000
Q3 2021 Nov 01, 2021	BUY	$1.27 - $8.17 $61,639 - $396,530	48,535 New	48,535 $64,000
Q2 2021 Aug 12, 2021	SELL	$6.55 - $8.98 $104,217 - $142,880	-15,911 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.1 - $7.69 $30,414 - $38,342	4,986 Added 45.64%	15,911 $105,000
Q4 2020 Feb 04, 2021	BUY	$5.05 - $7.1 $55,171 - $77,567	10,925 New	10,925 $71,000
Q3 2020 Nov 09, 2020	SELL	$5.25 - $7.08 $97,707 - $131,765	-18,611 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$5.37 - $8.11 $29,438 - $44,459	-5,482 Reduced 22.75%	18,611 $129,000
Q1 2020 Apr 30, 2020	BUY	$4.35 - $8.79 $48,789 - $98,588	11,216 Added 87.1%	24,093 $137,000
Q4 2019 Jan 28, 2020	BUY	$4.23 - $8.29 $54,469 - $106,750	12,877 New	12,877 $97,000
Q3 2019 Nov 04, 2019	SELL	$2.15 - $6.28 $55,491 - $162,086	-25,810 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$2.49 - $3.73 $64,266 - $96,271	25,810 New	25,810 $69,000
Q1 2019 Apr 29, 2019	SELL	$1.88 - $3.35 $51,869 - $92,426	-27,590 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$1.66 - $4.16 $45,799 - $114,774	27,590 New	27,590 $49,000
Q4 2017 Jan 24, 2018	SELL	$4.85 - $7.8 $77,905 - $125,291	-16,063 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$4.35 - $5.7 $69,874 - $91,559	16,063	16,063 $90,000

Others Institutions Holding ARDX

# of Institutions

244

Shares Held

161M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Ardelyx, Inc. Transaction History